Kynam Capital Management, LP - 31 Dec 2025 SCHEDULE 13G Report for CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share (CTMX)

Filing Manager
Kynam Capital Management, LP
Reporting Manager
Kynam Capital Management, LP
Security
CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share
Symbol
CTMX
Shares outstanding
169,491,059 shares
Disclosed Ownership
8,966,077 shares
Ownership
5.3%
Form type
SCHEDULE 13G
Filing time
04 Mar 2026, 15:18:13 UTC
Date of event
31 Dec 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Kynam Capital Management, LP 5.3% 8,966,077 0 8,966,077 Yue Tang Managing Member
Kynam Capital Management GP, LLC 5.3% 8,966,077 0 8,966,077 Yue Tang Managing Member
Yue Tang 5.3% 8,966,077 0 8,966,077 Yue Tang Self